BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 23 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13 | -43.5% | 33 | 0.0% | 0.00% | – |
| Q2 2023 | $23 | -100.0% | 33 | -100.0% | 0.00% | -100.0% |
| Q1 2023 | $7,112,574 | +534680.0% | 901,467 | +60933.6% | 0.00% | – |
| Q4 2022 | $1,330 | -33.5% | 1,477 | +0.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 1,470 | -0.2% | 0.00% | – |
| Q2 2022 | $2,000 | -60.0% | 1,473 | -32.9% | 0.00% | – |
| Q1 2022 | $5,000 | -70.6% | 2,195 | -60.0% | 0.00% | – |
| Q4 2021 | $17,000 | +142.9% | 5,487 | +201.0% | 0.00% | – |
| Q3 2021 | $7,000 | -22.2% | 1,823 | -10.5% | 0.00% | – |
| Q2 2021 | $9,000 | +800.0% | 2,038 | +972.6% | 0.00% | – |
| Q1 2021 | $1,000 | -97.1% | 190 | -96.4% | 0.00% | – |
| Q4 2020 | $34,000 | +36.0% | 5,225 | +115.2% | 0.00% | – |
| Q3 2020 | $25,000 | -35.9% | 2,428 | -21.6% | 0.00% | – |
| Q2 2020 | $39,000 | +34.5% | 3,098 | +17.7% | 0.00% | – |
| Q1 2020 | $29,000 | – | 2,633 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PFS Partners, LLC | 6,000 | $2,386 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 383,178 | $152 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 113,911 | $45,291 | 0.00% |
| OSAIC HOLDINGS, INC. | 557 | $221 | 0.00% |
| US BANCORP \DE\ | 1,221 | $485 | 0.00% |
| WELLS FARGO & COMPANY/MN | 180,066 | $71,594 | 0.00% |
| NORTHERN TRUST CORP | 30,251 | $12,028 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 2,100 | $840 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 95,656 | $38,262 | 0.00% |